Annual Congress Stockholm 2002

Saturday, 14.09.2002
Sunday, 15.09.2002
Monday, 16.09.2002
Tuesday, 17.09.2002
Wednesday, 18.09.2002

Citations should be made in the following way: Authors. Title. Eur Respir J 2002; 20: Suppl. 38, abstract number.

Material from 2002:

3388 Abstracts
6 Slide presentations
5 Handouts

Material from 2002: Show

Thoracic oncology: diagnosis and prognosis

Oral Presentation
Chairs: J. Vansteenkiste (Leuven, Belgium), A. Gröschel (Homburg, Germany)

Download all media

Expression of MAGE in the induced sputum of lung cancer patients M. H. Jung, T. W. Jang, C. H. Ok, C. H. Jeon, J. W. Park (Busan, South Korea)
Follow-up of patients with autofluorescence bronchoscopy B. Szima, J. Strausz (Torokbalint, Hungary)
Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer A. Gröschel, D. Hellwig, G. W. Sybrecht, C. M. Kirsch, D. Ukena (Homburg, Germany)
Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis D. Hellwig, A. Gröschel, G. W. Sybrecht, C. M. Kirsch, D. Ukena (Homburg, Germany)
MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC) D. Dworakowska, R. Schneider-Stock, E. Jassem, B. Peters, M. Zylicz, J. Limon, J. Jakobkiewicz, G. Kobierska, A. Szymanowska, J. Skokowski, A. Roessner, J. Jassem (Gdansk, Poland; Magdeburg, Germany)
Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database J. Vansteenkiste, C. Dooms, J. Vandebroek, K. Nackaerts, D. Galdermans, L. Bosquée, K. Deschepper, W. Van Kerckhoven, N. Dams (Leuven, Brussels, Belgium)
Stage IIIA-N2 non-small cell lung cancer (NSCLC): comparison of prognostic factors in 257 patients treated with surgery (S) versus induction chemotherapy plus surgery (IC+S) J. Vansteenkiste, C. Dooms, K. Nackaerts, P. De Leyn, B. Anrys, M. Demedts (Leuven, Belgium)